 1 Agents affecting nervous system and sensory organs
|
|
 2 Agents affecting individual organs
|
21 Cardiovascular agents
|
211 Cardiotonics
|
212 Antiarrhythmic agents
|
213 Diuretics
|
214 Antihypertensives
|
215 Capillary stabilizers
|
216 Vasoconstrictors
|
2160 Vasoconstrictors
|
 D00511 Phenylephrine hydrochloride (JP18/USP)
D01307 Midodrine hydrochloride (JAN/USP)
D00451 Sumatriptan (JAN/USP/INN)
D00676 Sumatriptan succinate (JAN/USP)
D00674 Naratriptan hydrochloride (JAN/USP)
D00415 Zolmitriptan (JAN/USP/INN)
D00675 Rizatriptan benzoate (JAN/USP)
D01973 Eletriptan hydrobromide (JAN/USAN)
|
217 Vasodilators
|
218 Hyperlipidemia agents
|
219 Miscellaneous
|
22 Respiratory organ agents
|
23 Digestive organ agents
|
24 Hormones
|
25 Urogenital and anal organ agents
|
26 Epidermides
|
27 Dental preparations
|
29 Other agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan